Oral presentation will showcase distinct preclinical profile for potent, selective MALT1 scaffolding inhibitor that is highly differentiated from MALT1 protease inhibitors BOSTON, Nov. 2, 2023...

– Results support axatilimab's promising safety and efficacy profile, and reinforce its potential as a first-in-class CSF-1R monoclonal antibody in chronic graft-versus-host disease – –...

Program participants have exclusive access to the RO element before commercial launch and receive special pricing incentives. BOSTON, Nov. 2, 2023 /PRNewswire/ -- ZwitterCo, the advanced membrane...

CSO Mike Train, CTO Peter Zornio and Power & Water President Bob Yeager will speak at Reuters Energy Transition North America 2023 Conference HOUSTON, Nov. 2, 2023 /PRNewswire/ -- Top executives...

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of pirtobrutinib, a non-covalent (reversible) Bruton's tyrosine kinase (BTK) inhibitor, will be presented at the 65th...

Cytrellis Biosystems, a pioneer in novel medical aesthetic solutions and manufacturer of ellacor® and its proprietary Micro-Coring® Technology, announced today that six abstracts demonstrating...

The Portuguese Health Food Brand Shines Out at the World's Leading Trade Fair for Food and Beverages FORT LAUDERDALE, Fla., Nov. 2, 2023 /PRNewswire/ -- The Anuga Fair is the world's leading trade...

eAssist Dental Solutions, the nation's leading dental billing company, is pleased to announce that two of its executives will be featured as presenters at the American Academy of Implant Dentistry...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced interim results from the ongoing open-label KINECT®-HD2 study about INGREZZA® (valbenazine) capsules when used for the long-term...

Leading Leisure & Entertainment Solutions Provider to Debut New, Cloud-Native Restaurant & Retail Platform, Comprehensive Ticketing Solution Upgrades, and More ORLANDO, Fla., Nov. 2, 2023...